Goldman Sachs’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-327,400
Closed -$17.2M 6070
2022
Q4
$17.2M Buy
+327,400
New +$16.6M ﹤0.01% 2093
2022
Q3
Sell
-225,000
Closed -$11.3M 6399
2022
Q2
$11.3M Buy
225,000
+203,900
+966% +$11.1M ﹤0.01% 2397
2022
Q1
$1.29M Buy
+21,100
New +$1.26M ﹤0.01% 4626
2017
Q4
Sell
-27,600
Closed -$768K 6492
2017
Q3
$768K Hold
27,600
﹤0.01% 4797
2017
Q2
$766K Buy
+27,600
New +$731K ﹤0.01% 4711

Other funds holding IHI

Goldman Sachs's IHI Position: Q1 2026 in Review

Goldman Sachs increased its iShares US Medical Devices ETF (IHI) stake by 671% in Q1 2026, buying an estimated $90.9M and bringing the position to 1,777,796 shares worth $94.8M. The position accounts for 0.01% of the portfolio, ranked #1063.

Goldman Sachs first reported a position in IHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $118M in Q2 2019. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Goldman Sachs held 1,777,796 shares of iShares US Medical Devices ETF worth $94.8M as of Q1 2026.
  • Goldman Sachs bought 1,547,315 iShares US Medical Devices ETF shares in Q1 2026, an estimated $90.9M.
  • iShares US Medical Devices ETF made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1063 holding.
  • Goldman Sachs first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's iShares US Medical Devices ETF position peaked at $118M in Q2 2019.
  • 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.